Mechanism and Clinical Research Progress of Nirmatrelvir Tablets/Ritonavir Tablets: A New Therapeutic Agent for COVID-19

ZHANG Jing-wen, HU Xin, ZHAO Zi-nan, JIN Peng-fei

Chinese Pharmaceutical Journal ›› 2022, Vol. 57 ›› Issue (10) : 845-850.

PDF(1406 KB)
PDF(1406 KB)
Chinese Pharmaceutical Journal ›› 2022, Vol. 57 ›› Issue (10) : 845-850. DOI: 10.11669/cpj.2022.10.012

Mechanism and Clinical Research Progress of Nirmatrelvir Tablets/Ritonavir Tablets: A New Therapeutic Agent for COVID-19

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 57(10): 845-850 https://doi.org/10.11669/cpj.2022.10.012

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1406 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉